Abstract
Opium (from the Greek word for juice — opion) comes from the seeds of the poppy Papaver somniferum. Evidence of early civilisations cultivating poppy seeds can be found from around 4000 BC and by 2000 BC knowledge of opium was widespread throughout Europe, the Middle East and North Africa, where it was considered a cure for all ailments. Opium was considered important in Greco-Roman pharmacy, and was used to alleviate pain as well as insomnia, coughs, bowel problems and a variety of other conditions. In Europe the use of opium declined with the collapse of the Roman Empire, but re-appeared with the return of the crusaders in the 12th and 13th centuries. By the sixteenth century opium had an established role as a medicine in Europe, and became increasingly popular in the 18th century.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pert CB, Snyder SH (1973) Properties of opiate receptor binding in rat brain. Proc Natl Acad Sci USA 70: 2243–2247
Simon EJ, Hiller JM, Edelman I (1973) Stereospecific binding of the potent narcotic analgesic [3H]etorphine to rat brain homogenates. Proc Natl Acad Sci USA 70: 1947–1949
Terenius L (1973) Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of the guinea-pig ileum. Acta Pharmacol Toxicol 32: 317–320
Hughes J (1975) Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res 88: 295–306
Hughes J, Smith TW, Fothergill LA et al (1975) Identification of two related peptides from the brain with potent opiate agonist activity. Nature 258: 577–579
Bradbury AF, Smythe DG, Snell CR (1976) C fragment of lipotropin has a high affinity for brain opiate receptors. Nature 260: 793–795
Goldstein A, Tachibana S, Lowney LI et al (1979) Dynorphin-(l-13), an extraordinarily potent opioid peptide. Proc Nat Acad Sci USA 76: 6666–6670
Martin WR, Eades CG, Thomson JA et al (1976) The effects of morphine and nalorphine like drugs in the non-dependent and morphine dependent chronic spinal dog. J Pharmacol Exp Therap 197: 517–532
Manallack DT, Beart PM, Gundlach AL (1986) Psychotomimetric G-opiates and PCP. Tr Pharmacol Sci 7: 448–451
Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW (1977) Endogenous opioid peptides; multiple agonists and receptors. Nature 267: 495–499
Zadina JE, Hackler L, Ge LJ, Kastin AJ (1997) A potent and selective endogenous agonist for the jn-opioid receptor. Nature 386: 499–502
Hacker L, Zadina JE, Ge LJ, Kastin AJ (1997) Isolation of relatively large amounts of endo-morphin-1 and endomorphin-2 from human brain cortex. Peptides 18: 1635–1639
Stone LS, Fairbanks CA, Laughlin TM et al (1997) Spinal analgesic actions of the new endogenous opioid peptides of endomorphin-1 and endomorphin-2. Neuroreport 8: 3131–3135
Goldberg IE, Rossi GC, Letch worth SR et al (1998) Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J Pharmacol Exp Ther 286: 1007–1013
Champion HC, Zadina JE, Kastin AJ, Kadowitz PJ (1997) The endogenous |Li-opioid receptor agonists, endomorphin-1 and 2 have vasodilator activity in the hindquarters vascular bed of the rat. Life Sci 61:PL409–415
Czapla MA, Champion HC, Zadina JE et al (1998) Endomorphin-1 and 2, endogenous |Li-opi-oid receptor agonists, decrease systemic arterial pressure in the rat. Life Sci 62:PL175–179
Yang YR, Chiu TH, Chen CL (1999) Structure activity relationships of naturally occurring and synthetic opioid tetrapeptides acting on locus ceruleus neurons. Eur J Pharmacol 372: 229–239
Corbett A, McKnight AT, Henderson G (1999) Opioid receptors. In: Tocris Cookson Ltd. sponsored receptor and ion channel nomenclature supplement (Elsiver Trends Journals )
Paul D, Standifer KM, Inturrisi CE, Pasternak GW (1989) Pharmacological characterization of morphine-6-beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Therap 251: 477–483
Brown GP, Yang K, Ouefelli O et al (1997) [3H]morphine-6-p-glucuronide binding in brain membranes and a MOR-1 transfected cell line. J Pharmacol Exp Therap 282: 1291–1297
Dhawan BN, Celsselin F, Raghubir R et al (1996) International Union of Pharmacology: 12. Classification of opioid receptors. Pharmacol Rev 48: 567–592
Kieffer B, Befort K, Gaveriaux-Ruff C, Hirth CG (1992) The delta-opioid receptor: isolation of cDNA by expression cloning and pharmacological characterization. Proc Nat Acad Sci USA 89: 12048–12052
Evans CJ, Keith DE, Morrison H et al (1992) Cloning of a delta-opioid receptor by functional expression. Science 258: 1952–1955
Yasuda K, Raynor K, Kong H et al (1993) Cloning and functional comparison of kappa-opi-oid and delta-opioid receptors from mouse-brain. Proc Natl Acad Sei USA 90: 6736–6740
Thompson RC, Mansour A, Akil H, Watson SJ (1993) Cloning and pharmacological characterization of a rat |H-opioid receptor. Neuron 11: 903–913
Birnbaumer L, Yatani A, Vandongen AMJ et al (1990) G-protein coupling of receptors to ionic channels and other effector systems. Br J CI Pharmacol 30: S13 - S22
Law PY, Loh HH (1999) Regulation of opioid receptor activities. J Pharmacol Exp Therap 289: 607–624
Pasternak GW, Wood PJ (1986) Multiple mu opiate receptors. Life Sei 38: 1889–1898
Cruciani RA, Dvorkin B, Klinger HP, Makman MH (1994) Presence in neuroblastoma cells of a mu(3) receptor with selectivity for opiate alkaloids but without affinity for opioid peptides. Brain Res 667: 229–237
Traynor JR, Elliott J (1993) Delta opioid receptor subtypes and cross-talk with mu-opioid receptors. Tr Pharmacol Sei 14: 84–86
Sofuoglu M, Portoghese PS, Takemori AE (1991) Differential antagonism of delta-opioid agonists by naltrindole and its benzofuran analogue ( NTB) in mice - evidence for delta-opioid receptor subtypes. J Pharmacol Exp Therap 257: 676–680
Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clin Neuropharma-col 16: 1–18
Cheng J, Standifer KM, Tublin PR et al (1995) Demonstration of K3-opioid receptors in the SH-SY5Y human neuroblastoma cell line. J Neurochem 65: 170–175
Foord SM, Marshall FH (1999) RAMPS; accessory proteins for seven transmembrane receptors. Tr Pharmacol Sei 20: 184–187
Rothman RB, Bykov V, Jacobson AE et al (1992) A study on the effect of [D-Ala- 2Leu5Cys6] Enkephalin on 5CX and 5ncx opioid receptor binding sites in vitro and in vivo. Peptides 92: 691–694
Joarden B, Devi LA (1999) G protein coupled receptor heterodimerization modulates receptor function. Nature 399: 697–700
Onaran HO, Gurdal H (1999) Ligand efficacy and affinity in an interacting 7tm receptor model. Tr Pharmacol Sei 20: 274–278
Zimprich A, Simon T, Hollt V (1995) rMORl and rMORIB: comparison of both rat ji-opioid receptor variants with respect to second messenger coupling. Analgesia 1: 886–889
Pan YX, Xu J, Bolan E et al (1999) Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms. Mol Pharmacol 56: 396–403
Pan ZZ (1998) M-opposing actions of the K-opioid receptor. Tr Pharmacol Sei 19: 94–98
Wei LN, Hu XL, Bi J, Loh H (2000) Post-transcriptional regulation of mouse kappa-opioid receptor expression. Mol Pharmacol 57: 401–408
Smart D, Hirst RA, Hirota K et al (1997) The effects of recombinant rat |H-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]j and adenylyl cyclase. Br J Pharmacol 120: 1165–1171
Hirst RA, Hirota K, Grandy DK, Lambert DG (1997) Coupling of the cloned rat K-opioid receptor to adenylyl cyclase is dependent on receptor expression. Neurosci Lett 232: 119–122
Hirst RA, Smart D, Devi LA, Lambert DG (1998) Effects of C-terminal truncation of the recombinant 8-opioid receptor on phospholipase C and adenylyl cyclase coupling. J Neurochem 70: 2273–2278
Ingram SL, Williams JT (1994) Opioid inhibition of I-h via adenylyl-cyclase. Neuron 13: 179–186
Seward E, Hammond C, Henderson G (1991) M-opioid-receptor-mediated inhibition of N- type calcium-channel current. Proc R Soc Lond 244: 129–135
Soldo BL, Moises HC (1998) M-opioid receptor activation inhibits N and P type Ca channel currents in magnocellular neurons of the rat supraoptic nucleus. J Physiol 513: 787–804
Piros IT, Hales TG, Evans CJ (1996) Functional analysis of cloned receptors in transfected cell lines. Neurochem Res 21: 1277–1285
Christie MJ, North RA, Surprenant A, Williams JT (1987) M-and 8-opioid receptors both belong to a family of neurotransmitter receptors which increase an inwardly rectifying potassium conductance. J Physiol 390: P199
Henry DJ, Grandy DK, Lester HA et al (1995) K-opioid receptors couple to inwardly rectifying potassium channels when coexpressed in Xenopus oocytes. J Pharmacol Exp Therap 47: 551–557
Han SH, Cho YW, Kim CJ et al (1999) M-opioid agonist induced activation of G protein coupled inwardly rectifying potassium current in rat periaqueductal gray neurons. Neurosci 90: 209–219
Mansour A, Khachaturian H, Lewis ME et al (1988) Anatomy of CNS opioid receptors. Tr Neurolog Sci 11: 308–314
George SR, Zastawny RL, Briones-Urbrina R et al (1994) Distinct distribution of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem Biophys Res Comm 205: 1438–1444
Matthes HWD, Maldonado R, Simonin F et al (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the ji-opioid receptor gene. Nature 383: 819–823
Kitchen I, Slowe S, Mattehes HWD, Kieffer B (1997) Quantitative autoradiographic mapping of 8-, and K-opioid receptors in knockout mice lacking the |i-opioid receptor gene. Brain Res 778: 73–88
Simonin F, Valverde O, Smadja C et al (1998) Disruption of the K-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of U50–4088H and attenuates morphine withdrawl. EMBO J 17: 886–897
Zhu YX, King MA, Schuller AGP et al (1999) Retention of delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24: 243–252
Caló G, Guerrini R, Rizzi A et al (2000) Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol 129: 1261–1283
Meunier JC, Mollereau C, Toll L et al (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL(l) receptor. Nature 377: 532–535
Reinscheid RK, Northacker HP, Bourson A et al (1995) Orphanin-FQ–a neuropeptide that activates an opioid-like G-protein-coupled receptor. Science 270: 792–794
Darland T, Grandy DK (1998) The orphanin FQ system: an emerging target for the management of pain? Br J Anaesth 81: 29–37
Sanders VM (1995) The role of opioid peptides in immune function. In: Tseng LF (ed) The pharmacology of opioid peptides. Harvard Academic Publishers, USA
Webster NR (1998) Opioids and the immune system. Br J Anaesth 81: 835–836
Schaible HG, Grubb BD (1993) Afferent and spinal mechanisms of joint pain. Pain 55: 5–54
Zhou LI, Zhang Q, Stein C, Schafer M (1998) Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 286: 1000–1006
Paakkari P, Feuerstein G (1995) Opioid peptides in cardiovascular and respiratory regulation. In: Tseng LF (ed) The pharmacology of opioid peptides. Harvard Academic Publishers, USA
Burks TF (1995) Opioid peptides in gastrointestinal functions. In: Tseng LF (ed) The pharmacology of opioid peptides. Harvard Academic Publishers, USA
Crighton IM, Martin PH, Hobbs GJ et al (1998) A comparison of the effects of intravenous tramadol, codeine and morphine on gastric emptying in human volunteers. Anaes Analg 87: 445–449
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Italia
About this paper
Cite this paper
Harrison, C., Lambert, D.G. (2001). Opioid Pharmacology. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/978-88-470-2903-3_37
Download citation
DOI: https://doi.org/10.1007/978-88-470-2903-3_37
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0136-7
Online ISBN: 978-88-470-2903-3
eBook Packages: Springer Book Archive